Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""MULTIPLE sclerosis"" wg kryterium: Temat


Starter badań:

Tytuł :
Beliefs about medication as predictors of medication adherence in a prospective cohort study among persons with multiple sclerosis.
Autorzy :
Neter E; Ruppin Academic Center, 3 Bait, Ruppin Academic Center, 4025000, Emeq Hefer, Israel. .
Glass-Marmor L; Rappaport Faculty of Medicine, Technion Institute of Technology, Haifa, Israel.
Wolkowitz A; Rappaport Faculty of Medicine, Technion Institute of Technology, Haifa, Israel.
Lavi I; Department of Community Medicine & Epidemiology, Carmel Medical Center, Haifa, Israel.
Miller A; Rappaport Faculty of Medicine, Technion Institute of Technology, Haifa, Israel.; Multiple Sclerosis Center & Department of Neurology, Carmel Medical Center, Haifa, Israel.
Pokaż więcej
Źródło :
BMC neurology [BMC Neurol] 2021 Mar 25; Vol. 21 (1), pp. 136. Date of Electronic Publication: 2021 Mar 25.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Medication Adherence/*psychology
Multiple Sclerosis, Relapsing-Remitting/*drug therapy
Adult ; Female ; Humans ; Male ; Medication Adherence/statistics & numerical data ; Middle Aged ; Multiple Sclerosis ; Patient Reported Outcome Measures ; Prospective Studies ; Retrospective Studies ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
Family planning is the second most relevant factor for treatment decisions after disease activity - No.
Autorzy :
Oreja-Guevara C; Department of Neurology, Hospital Clínico San Carlos, Madrid, Spain/Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid (UCM), IdISSC, Madrid, Spain.
Pokaż więcej
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2020 May; Vol. 26 (6), pp. 642-643. Date of Electronic Publication: 2020 Feb 21.
Typ publikacji :
Journal Article
MeSH Terms :
Decision Making*
Immunologic Factors*/administration & dosage
Immunologic Factors*/adverse effects
Multiple Sclerosis*/complications
Multiple Sclerosis*/drug therapy
Pregnancy Complications*/drug therapy
Reproductive Behavior*
Female ; Humans ; Multiple Sclerosis, Relapsing-Remitting/complications ; Multiple Sclerosis, Relapsing-Remitting/drug therapy ; Pregnancy
Czasopismo naukowe
Tytuł :
Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data.
Autorzy :
Ohlmeier C; Department Health Services Research, IGES Institut GmbH, Berlin, Germany.
Gothe H; Department Health Services Research, IGES Institut GmbH, Berlin, Germany.; Chair for Health Sciences / Public Health, Medical Faculty 'Carl Gustav Carus', Technical University Dresden, Dresden, Germany.; Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i.T., Austria.
Haas J; Center for Multiple Sclerosis, Jewish Hospital Berlin, Berlin, Germany.
Osowski U; Merck Serono GmbH, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany.
Weinhold C; Merck Serono GmbH, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany.
Blauwitz S; Department Health Services Research, IGES Institut GmbH, Berlin, Germany.
Schmedt N; InGef - Institute for Applied Health Research Berlin GmbH, Berlin, Germany.
Galetzka W; InGef - Institute for Applied Health Research Berlin GmbH, Berlin, Germany.
Berkemeier F; Department Health Services Research, IGES Institut GmbH, Berlin, Germany.
Tackenberg B; Center of Neuroimmunology, Philipps-University, Marburg, Germany.
Stangel M; Clinical Neuroimmunology and Neurochemistry, Dept. of Neurology, Hannover Medical School, Hannover, Germany.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 May 01; Vol. 15 (5), pp. e0231846. Date of Electronic Publication: 2020 May 01 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Multiple Sclerosis, Relapsing-Remitting*/epidemiology
Adolescent ; Adult ; Child ; Child, Preschool ; Cohort Studies ; Comorbidity ; Female ; Germany ; Humans ; Incidence ; Infant ; Infant, Newborn ; Male ; Middle Aged ; Multiple Sclerosis/drug therapy ; Multiple Sclerosis/epidemiology ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Identification and diagnosis of Secondary Progressive Multiple Sclerosis during the clinical encounter: Results from a physician survey.
Autorzy :
Alvarez E; Rocky Mountain Multiple Sclerosis Center at the University of Colorado, Aurora, CO, USA.
Nair KV; Rocky Mountain Multiple Sclerosis Center at the University of Colorado, Aurora, CO, USA.
Gorritz M; IQVIA, Inc, Plymouth Meeting, PA, USA.
Bartolome L; Thomas Jefferson University, Philadelphia, PA, USA.
Maloney H; IQVIA, Inc, Plymouth Meeting, PA, USA.
Ding Y; IQVIA, Inc, Plymouth Meeting, PA, USA.
Golan T; IQVIA, Inc, Plymouth Meeting, PA, USA.
Wade RL; IQVIA, Inc, Plymouth Meeting, PA, USA.
Kumar R; IQVIA, Inc, Plymouth Meeting, PA, USA.
Su W; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Shah R; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Russo P; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Pokaż więcej
Źródło :
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2021 May; Vol. 50, pp. 102858. Date of Electronic Publication: 2021 Feb 23.
Typ publikacji :
Journal Article
MeSH Terms :
Multiple Sclerosis*
Multiple Sclerosis, Chronic Progressive*/diagnosis
Multiple Sclerosis, Chronic Progressive*/epidemiology
Multiple Sclerosis, Chronic Progressive*/therapy
Multiple Sclerosis, Relapsing-Remitting*/diagnosis
Multiple Sclerosis, Relapsing-Remitting*/epidemiology
Multiple Sclerosis, Relapsing-Remitting*/therapy
Physicians*
Cross-Sectional Studies ; Disease Progression ; Humans ; Retrospective Studies ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis.
Autorzy :
Petrou P; Unit of Neuroimmunology and Multiple Sclerosis Center, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Kassis I; Unit of Neuroimmunology and Multiple Sclerosis Center, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Levin N; Department of Neurology and The Agnes-Ginges Center for Neurogenetics, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Paul F; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Backner Y; Department of Neurology and The Agnes-Ginges Center for Neurogenetics, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Benoliel T; Department of Neurology and The Agnes-Ginges Center for Neurogenetics, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Oertel FC; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Scheel M; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Department of Neuroradiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Hallimi M; Unit of Neuroimmunology and Multiple Sclerosis Center, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Yaghmour N; Unit of Neuroimmunology and Multiple Sclerosis Center, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Hur TB; Department of Neurology and The Agnes-Ginges Center for Neurogenetics, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Ginzberg A; Unit of Neuroimmunology and Multiple Sclerosis Center, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Levy Y; Unit of Neuroimmunology and Multiple Sclerosis Center, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Abramsky O; Department of Neurology and The Agnes-Ginges Center for Neurogenetics, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Karussis D; Unit of Neuroimmunology and Multiple Sclerosis Center, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Pokaż więcej
Źródło :
Brain : a journal of neurology [Brain] 2020 Dec 01; Vol. 143 (12), pp. 3574-3588.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Mesenchymal Stem Cell Transplantation/*methods
Multiple Sclerosis/*therapy
Adult ; Brain/diagnostic imaging ; Disease Progression ; Double-Blind Method ; Endpoint Determination ; Female ; Follow-Up Studies ; Humans ; Injections, Intravenous ; Injections, Spinal ; Magnetic Resonance Imaging ; Male ; Mesenchymal Stem Cell Transplantation/adverse effects ; Middle Aged ; Multiple Sclerosis/diagnostic imaging ; Multiple Sclerosis/psychology ; Multiple Sclerosis, Chronic Progressive/therapy ; Neuropsychological Tests ; Recurrence ; Tomography, Optical Coherence ; Treatment Outcome ; Walking
Czasopismo naukowe
Tytuł :
Long-term management of multiple sclerosis patients treated with cladribine tablets: an expert opinion.
Autorzy :
Meuth SG; Abteilung für Neurologie, Universitätsklinikum Münster , Münster, Germany.
Bayas A; Klinik für Neurologie und Klinische Neurophysiologie, Universitätsklinikum Augsburg , Germany.
Kallmann B; Multiple Sklerose Zentrum Bamberg , Germany.
Kleinschnitz C; Klinik für Neurologie, Universitätsklinikum Essen , Germany.
Linker R; Klinik und Poliklinik für Neurologie, Universitätsklinikum Regensburg , Germany.
Rieckmann P; Abteilung für Neurologie, Medical Park Loipl , Germany.
Mäurer M; Klinik für Neurologie, Juliusspital Würzburg Klinikum Würzburg Mitte gGmbH , Germany.
Pokaż więcej
Źródło :
Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2020 Nov; Vol. 21 (16), pp. 1965-1969. Date of Electronic Publication: 2020 Jul 13.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Cladribine/*therapeutic use
Immunosuppressive Agents/*therapeutic use
Multiple Sclerosis/*drug therapy
Administration, Oral ; Cladribine/administration & dosage ; Cladribine/adverse effects ; Clinical Trials as Topic ; Drug Administration Schedule ; Drug Monitoring ; Expert Testimony ; Humans ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/adverse effects ; Multiple Sclerosis/immunology ; Multiple Sclerosis, Relapsing-Remitting/drug therapy ; Multiple Sclerosis, Relapsing-Remitting/immunology ; Practice Guidelines as Topic ; Recurrence ; Tablets ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Disease modifying therapies in relapsing-remitting multiple sclerosis: A systematic review and network meta-analysis.
Autorzy :
Liu Z; Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Liao Q; Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Wen H; Xiangya Hospital, Central South University, Changsha, Hunan, China.
Zhang Y; Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China. Electronic address: .
Pokaż więcej
Źródło :
Autoimmunity reviews [Autoimmun Rev] 2021 Jun; Vol. 20 (6), pp. 102826. Date of Electronic Publication: 2021 Apr 18.
Typ publikacji :
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms :
Multiple Sclerosis*
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Humans ; Immunologic Factors ; Immunosuppressive Agents/therapeutic use ; Natalizumab ; Network Meta-Analysis
Czasopismo naukowe
Tytuł :
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study.
Autorzy :
De Mercanti SF; Clinical and Biological Sciences Department, Neurology Unit, University of Torino, San Luigi Gonzaga Hospital, Orbassano, Torino, Italy. Electronic address: .
Signori A; Department of Health Sciences, Section of Biostatistics, University of Genova, Italy.
Cordioli C; Multiple Sclerosis Center, Spedali Civili of Brescia, Presidio di Montichiari, Brescia, Italy.
Signoriello E; Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, Italy.
Lus G; Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, Italy.
Bonavita S; Clinic of Neurology, AOU - University of Campania 'Luigi Vanvitelli', Napoli, Italy.
Abbadessa G; Clinic of Neurology, AOU - University of Campania 'Luigi Vanvitelli', Napoli, Italy.
Lavorgna L; Clinic of Neurology, AOU - University of Campania 'Luigi Vanvitelli', Napoli, Italy.
Maniscalco GT; Neurological Clinic and Multiple Sclerosis Centre of 'AORN A.Cardarelli', Naples, Italy.
Curti E; Neurology Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.
Lorefice L; Multiple Sclerosis Center, Binaghi Hospital, Department of Medical Sciences and Public Health, University of Cagliari, Italy.
Cocco E; Multiple Sclerosis Center, Binaghi Hospital, Department of Medical Sciences and Public Health, University of Cagliari, Italy.
Nociti V; Multiple Sclerosis Center, Neuroscience Area, Neuroscience, Aging, Head and Neck and Orthopaedics Sciences Department, Fondazione Policlinico Universitario Gemelli, Roma, Italy.
Mirabella M; Multiple Sclerosis Center, Neuroscience Area, Neuroscience, Aging, Head and Neck and Orthopaedics Sciences Department, Fondazione Policlinico Universitario Gemelli, Roma, Italy.
Baroncini D; Centro Sclerosi Multipla - Presidio ospedaliero di Gallarate - ASST Valle Olona, Italy.
Mataluni G; UOSD Centro di Riferimento Regionale Sclerosi Multipla - Dipartimento di Neuroscienze Policlinico Tor Vergata, Roma, Italy.
Landi D; UOSD Centro di Riferimento Regionale Sclerosi Multipla - Dipartimento di Neuroscienze Policlinico Tor Vergata, Roma, Italy.
Petruzzo M; Department of Neurosciences, Reproductive Sciences and Odontostomatology, Multiple Sclerosis Centre, Federico II University, Naples, Italy.
Lanzillo R; Department of Neurosciences, Reproductive Sciences and Odontostomatology, Multiple Sclerosis Centre, Federico II University, Naples, Italy.
Gandoglia I; Dept of Neuroscience, Rehabilititation, Ophthalmology, Genetics, Maternal and Child Health, Center of Excellence for Biomedical Research, University of Genova, Italy.
Laroni A; IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Frangiamore R; Department of Neuroimmunology and Neuromuscular Diseases, Neurological Institute C. Besta, IRCCS Foundation, Milan, Italy.
Sartori A; Neurology Unit, Azienda Sanitaria Univeristaria Integrata Clinica Neurologica, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Trieste, Italy.
Cavalla P; Department of Neuroscience, Città della Salute e della Scienza di Torino University Hospital, Torino, Italy.
Costantini G; Department of Neuroscience, Città della Salute e della Scienza di Torino University Hospital, Torino, Italy.
Capra R; Multiple Sclerosis Center, Spedali Civili of Brescia, Presidio di Montichiari, Brescia, Italy.
Sormani MP; Clinical and Biological Sciences Department, Neurology Unit, University of Torino, San Luigi Gonzaga Hospital, Orbassano, Torino, Italy.
Clerico M; Clinical and Biological Sciences Department, Neurology Unit, University of Torino, San Luigi Gonzaga Hospital, Orbassano, Torino, Italy.
Pokaż więcej
Źródło :
Journal of the neurological sciences [J Neurol Sci] 2021 May 15; Vol. 424, pp. 117385. Date of Electronic Publication: 2021 Mar 06.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Leukoencephalopathy, Progressive Multifocal*
Multiple Sclerosis*/diagnostic imaging
Multiple Sclerosis*/drug therapy
Multiple Sclerosis, Relapsing-Remitting*
Humans ; Immunologic Factors/adverse effects ; Italy ; Magnetic Resonance Imaging ; Natalizumab/adverse effects ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Fingolimod as an effective therapeutic strategy for pediatric relapsing-remitting multiple sclerosis: two case reports.
Autorzy :
Zanetta C; Neurology Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy.
Filippi M; Neurology Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy. .; Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. .; Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy. .; Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy. .; Vita-Salute San Raffaele University , Milan, Italy. .
Moiola L; Neurology Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy.
Pokaż więcej
Źródło :
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2021 May; Vol. 42 (Suppl 1), pp. 9-13. Date of Electronic Publication: 2021 Apr 27.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Multiple Sclerosis*
Multiple Sclerosis, Relapsing-Remitting*/diagnostic imaging
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Adult ; Child ; Fingolimod Hydrochloride/therapeutic use ; Humans ; Immunosuppressive Agents/therapeutic use ; Italy ; United States
Czasopismo naukowe
Tytuł :
Long-term fingolimod treatment in two pediatric patients with multiple sclerosis.
Autorzy :
Borriello G; Sant'Andrea Hospital, Rome, Italy. .
Pozzilli C; Department of Neurology and Psychiatry, La Sapienza University of Rome, Rome, Italy.
Pokaż więcej
Źródło :
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2021 May; Vol. 42 (Suppl 1), pp. 29-36. Date of Electronic Publication: 2021 Mar 10.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Multiple Sclerosis*
Multiple Sclerosis, Relapsing-Remitting*/diagnostic imaging
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Child ; Female ; Fingolimod Hydrochloride/therapeutic use ; Humans ; Immunosuppressive Agents/therapeutic use ; Interferon beta-1a ; Male ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Efficacy of fingolimod after switching from interferon β-1a in an adolescent with multiple sclerosis: case report.
Autorzy :
Amidei A; Department of Clinical and Experimental Medicine, Neurology Unit, Azienda Ospedaliero Universitaria Pisana, University of Pisa, via Roma 67, 56126, Pisa, Italy. .
Siciliano G; Department of Clinical and Experimental Medicine, Neurology Unit, Azienda Ospedaliero Universitaria Pisana, University of Pisa, via Roma 67, 56126, Pisa, Italy.
Pasquali L; Department of Clinical and Experimental Medicine, Neurology Unit, Azienda Ospedaliero Universitaria Pisana, University of Pisa, via Roma 67, 56126, Pisa, Italy.
Pokaż więcej
Źródło :
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2021 May; Vol. 42 (Suppl 1), pp. 5-7. Date of Electronic Publication: 2021 Mar 16.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Multiple Sclerosis*
Multiple Sclerosis, Relapsing-Remitting*/diagnostic imaging
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Adolescent ; Adult ; Child ; Female ; Fingolimod Hydrochloride/therapeutic use ; Glatiramer Acetate ; Humans ; Immunosuppressive Agents/therapeutic use ; Interferon beta-1a/therapeutic use
Czasopismo naukowe
Tytuł :
The concurrence of multiple sclerosis and glioblastoma.
Autorzy :
Alkabie S; Maxine Mesinger Multiple Sclerosis Comprehensive Care Center, Department of Neurology, Baylor College of Medicine, Houston, TX, USA. Electronic address: .
Castrodad-Molina R; Maxine Mesinger Multiple Sclerosis Comprehensive Care Center, Department of Neurology, Baylor College of Medicine, Houston, TX, USA.
Heck KA; Department of Pathology, Baylor College of Medicine, Houston, TX, USA.
Mandel J; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Hutton GJ; Maxine Mesinger Multiple Sclerosis Comprehensive Care Center, Department of Neurology, Baylor College of Medicine, Houston, TX, USA.
Pokaż więcej
Źródło :
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2021 May; Vol. 50, pp. 102877. Date of Electronic Publication: 2021 Mar 02.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Glioblastoma*/complications
Glioblastoma*/diagnostic imaging
Glioblastoma*/epidemiology
JC Virus*
Multiple Sclerosis*/complications
Multiple Sclerosis*/drug therapy
Multiple Sclerosis*/epidemiology
Multiple Sclerosis, Relapsing-Remitting*
Dimethyl Fumarate ; Female ; Humans ; Immunosuppressive Agents ; Middle Aged
Raport
Tytuł :
Fingolimod as first-line treatment in pediatric-onset multiple sclerosis: a case report.
Autorzy :
Capobianco M; Department of Neurology and Regional Referral Multiple Sclerosis Centre, University-Hospital San Luigi, Orbassano, Italy. .
Bertolotto A; Department of Neurology and Regional Referral Multiple Sclerosis Centre, University-Hospital San Luigi, Orbassano, Italy.
Malucchi S; Department of Neurology and Regional Referral Multiple Sclerosis Centre, University-Hospital San Luigi, Orbassano, Italy.
Pokaż więcej
Źródło :
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2021 May; Vol. 42 (Suppl 1), pp. 25-28. Date of Electronic Publication: 2021 Mar 12.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Multiple Sclerosis*/diagnostic imaging
Multiple Sclerosis*/drug therapy
Multiple Sclerosis, Relapsing-Remitting*/diagnostic imaging
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Adolescent ; Child ; Disease Progression ; Female ; Fingolimod Hydrochloride/therapeutic use ; Humans ; Immunosuppressive Agents/therapeutic use ; Magnetic Resonance Imaging ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Short-term data on disease activity, cognition, mood, stigma and employment outcomes in a cohort of patients with primary progressive multiple sclerosis (UPPMS study).
Autorzy :
Pérez-Miralles F; Neuroimmunology Unit, Neurology Department, Hospital Universitari i Politècnic La Fe, Avenida de Fernando Abril Martorell, 106, 46026 Valencia, Spain. Electronic address: .
Prefasi D; Medical Department, Roche Farma S.A., Calle de la Ribera del Loira, 50, 28042 Madrid, Spain.
García-Merino A; Neurology Department, Hospital Universitario Puerta de Hierro, Calle Manuel de Falla, 1, 28222 Majadahonda Spain.
Ara JR; Neurology Department, Hospital Universitario Miguel Servet, Paseo Isabel la Católica, 1-3, 50009 Zaragoza, Spain.
Izquierdo G; Neurology Department, Hospital Universitario Virgen Macarena, Calle Dr Fedriani, 3, 41009 Seville, Spain.
Meca-Lallana V; Neurology Department, Hospital Universitario La Princesa, Calle de Diego de León, 62, 28006 Madrid, Spain.
Gascón-Giménez F; Neurology Department, Hospital Clínico Universitario de Valencia, Avenida de Blasco Ibáñez, 17, 46010 Valencia, Spain.
Martínez-Ginés ML; Neurology Department, Hospital Universitario Gregorio Marañón, Calle del Dr Esquerdo, 46, 28007 Madrid, Spain.
Ramió-Torrentà L; Girona Neuroimmunology and Multiple Sclerosis Unit, Neurology Department, Hospital Universitari Josep Trueta and Hospital Santa Caterina, Avenida de Francia, S/N, 17007 Girona, Spain. IDIBGI Calle Dr. Castany s/n, Salt, 17190 Spain. Medical Sciences Department, Faculty of Medicine, University of Girona, Plaça Sant Domènec, 3 17400 Girona, Spain.
Costa-Frossard L; Neurology Department, Hospital Universitario Ramón y Cajal, Carretera de Colmenar Viejo km 9.100, 28034 Madrid, Spain.
Fernández Ó; Neurology Department, Hospital Regional Universitario Carlos Haya, Avenida de Carlos Haya, 84, 29010 Málaga, Spain.
Moreno-García S; Neurology Department, Hospital Universitario 12 de Octubre, Avenida de Córdoba, S/N, 28041 Madrid, Spain.
Medrano N; Medical Department, Roche Farma S.A., Calle de la Ribera del Loira, 50, 28042 Madrid, Spain.
Maurino J; Medical Department, Roche Farma S.A., Calle de la Ribera del Loira, 50, 28042 Madrid, Spain.
Casanova B; Neuroimmunology Unit, Neurology Department, Hospital Universitari i Politècnic La Fe, Avenida de Fernando Abril Martorell, 106, 46026 Valencia, Spain.
Pokaż więcej
Źródło :
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2021 May; Vol. 50, pp. 102860. Date of Electronic Publication: 2021 Feb 23.
Typ publikacji :
Journal Article
MeSH Terms :
Multiple Sclerosis*/diagnostic imaging
Multiple Sclerosis, Chronic Progressive*/diagnostic imaging
Adult ; Cognition ; Cohort Studies ; Disease Progression ; Employment ; Humans ; Prospective Studies
Czasopismo naukowe
Tytuł :
Psychometric properties of the Croatian version of the depression, anxiety, and stress scale-21 and multiple sclerosis impact scale-29 in multiple sclerosis patients.
Autorzy :
Rogić Vidaković M; University of Split, School of Medicine, Department of Neuroscience, Laboratory for Human and Experimental Neurophysiology (LAHEN), Split, Croatia. Electronic address: .
Šimić N; University of Zadar, Department of Psychology, Zadar, Croatia.
Poljičanin A; Clinical Hospital Split, Institute of Physical Medicine and Rehabilitation with Rheumatology, Split, Croatia; University of Split, Department of Health Studies, Split, Croatia.
Nikolić Ivanišević M; University of Zadar, Department of Psychology, Zadar, Croatia.
Ana J; University of Split, School of Medicine, Department of Neuroscience, Laboratory for Human and Experimental Neurophysiology (LAHEN), Split, Croatia.
Đogaš Z; University of Split, School of Medicine, Department of Neuroscience, Laboratory for Human and Experimental Neurophysiology (LAHEN), Split, Croatia; Split Sleep Medical Center, University of Split, Split, Croatia.
Pokaż więcej
Źródło :
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2021 May; Vol. 50, pp. 102850. Date of Electronic Publication: 2021 Feb 20.
Typ publikacji :
Journal Article
MeSH Terms :
Multiple Sclerosis*/complications
Multiple Sclerosis*/diagnosis
Anxiety/diagnosis ; Croatia/epidemiology ; Depression/diagnosis ; Humans ; Psychometrics ; Reproducibility of Results ; Stress, Psychological/diagnosis ; Stress, Psychological/epidemiology ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis.
Autorzy :
Wesnes K; Department of Clinical Medicine, University of Bergen, Bergen, Norway; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway; Department of Neurology, St. Olav's University Hospital, Trondheim, Norway. Electronic address: .
Myhr KM; Department of Clinical Medicine, University of Bergen, Bergen, Norway; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway.
Riise T; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Kvistad SS; Department of Clinical Medicine, University of Bergen, Bergen, Norway; Department of Immunology and Transfusion medicine, Haukeland University Hospital, Bergen, Norway.
Torkildsen Ø; Department of Clinical Medicine, University of Bergen, Bergen, Norway; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway.
Wergeland S; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway; Norwegian Multiple Sclerosis Competence Center, Department of Neurology, Haukeland University Hospital, Bergen, Norway.
Holmøy T; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Neurology, Akershus University Hospital, Lørenskog, Norway.
Midgard R; Department of Neurology, Molde Hospital, Molde, Norway.
Bru A; Department of Neurology, Stavanger University Hospital, Stavanger, Norway.
Edland A; Department of Neurology, Vestre Viken Hospital Trust, Drammen, Norway.
Eikeland R; Department of Neurology and Department of Paediatrics, Sørlandet Hospital Trust, Arendal, Norway.
Gosal S; Department of Neurology, Østfold Hospital Kalnes, Grålum, Norway.
Harbo HF; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Neurology, Oslo University Hospital Ullevaal, Oslo, Norway.
Kleveland G; Department of Neurology, Innlandet Hospital Lillehammer, Lillehammer, Norway.
Sørenes YS; Department of Neurology, Haugesund Hospital, Haugesund, Norway.
Øksendal N; Department of Neurology, Nordland hospital trust, Bodø, Norway.
Bjørnevik K; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Pokaż więcej
Źródło :
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2021 May; Vol. 50, pp. 102801. Date of Electronic Publication: 2021 Jan 28.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Multiple Sclerosis*/epidemiology
Multiple Sclerosis, Relapsing-Remitting*
Body Mass Index ; Disease Progression ; Follow-Up Studies ; Humans ; Prospective Studies ; Tobacco Use ; Vitamin D
Czasopismo naukowe
Tytuł :
Asymptomatic bradycardia after first fingolimod dose in a pediatric patient with multiple sclerosis - a case report.
Autorzy :
Petruzzo M; Federico II University of Naples, Naples, Italy.
Lanzillo R; Federico II University of Naples, Naples, Italy. .
Pokaż więcej
Źródło :
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2021 May; Vol. 42 (Suppl 1), pp. 37-39. Date of Electronic Publication: 2021 Feb 26.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Multiple Sclerosis*
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Adolescent ; Bradycardia/chemically induced ; Child ; Female ; Fingolimod Hydrochloride/adverse effects ; Humans ; Immunosuppressive Agents/adverse effects
Czasopismo naukowe
Tytuł :
Approaches and challenges in the diagnosis and management of secondary progressive multiple sclerosis: A Central Eastern European perspective from healthcare professionals.
Autorzy :
Boyko A; Department of Neurology, Neurosurgery and Medical Genetics, Pirogov's Russian National Research Medical University, Moscow, Russian Federation; Department of Neuropharmacology, Federal Center of Brain and Neurotechnology, Moscow, Russian Federation. Electronic address: .
Therapontos C; Novartis Pharma Services Inc., Cyprus.
Horakova D; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine Charles University and General University Hospital in Prague, Czech Republic.
Szilasiová J; Department of Neurology, Faculty of Medicine, P. J. Safarik University, Kosice, Slovakia.
Kalniņa J; Centre of Multiple Sclerosis, Latvian Maritime Medicine Centre, Rīga, Latvija.
Kolontareva J; Novartis Pharma LLC., Moscow, Russian Federation.
Gross-Paju K; West-Tallinn Central Hospital Centre for Neurological Diseases, Tallinn, Estonia; TalTech, Tallinn, Estonia.
Selmaj K; Center for Neurology, Lodz, Poland; Collegium Medicum, Department of Neurology, University of Warmia and Mazury, Olsztyn, Poland.
Sereike I; Centre of Neurology, Vilnius University, Vilnius, Lithuania.
Milo R; Department of Neurology, Barzilai Medical Center, Ashkelon, Faculty of Health Sciences, Ben-Gurion University of the Negev, Israel.
Gabelić T; Department of Neurology, Referral Center for Autonomic Nervous System Disorders, University Hospital Center Zagreb, Zagreb, Croatia; School of Medicine, University of Zagreb, Zagreb, Croatia.
Rot U; Department of Neurology University Medical Center Ljubljana, Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Pokaż więcej
Źródło :
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2021 May; Vol. 50, pp. 102778. Date of Electronic Publication: 2021 Jan 28.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Multiple Sclerosis*/diagnosis
Multiple Sclerosis*/epidemiology
Multiple Sclerosis*/therapy
Multiple Sclerosis, Chronic Progressive*/diagnosis
Multiple Sclerosis, Chronic Progressive*/epidemiology
Multiple Sclerosis, Chronic Progressive*/therapy
Multiple Sclerosis, Relapsing-Remitting*
Adult ; Delivery of Health Care ; Disease Progression ; Europe ; Humans ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Disease modifying therapies for relapsing-remitting multiple sclerosis: Use and costs in Australia (1996-2019).
Autorzy :
Goudarzi MH; School of Pharmacy, The University of Queensland, Australia. Electronic address: .
Eadie MJ; School of Medicine, The University of Queensland, Australia. Electronic address: .
Hollingworth SA; School of Pharmacy, The University of Queensland, Australia. Electronic address: .
Pokaż więcej
Źródło :
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2021 May; Vol. 50, pp. 102835. Date of Electronic Publication: 2021 Feb 10.
Typ publikacji :
Journal Article
MeSH Terms :
Multiple Sclerosis*
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Multiple Sclerosis, Relapsing-Remitting*/epidemiology
Aged ; Australia/epidemiology ; Fingolimod Hydrochloride/therapeutic use ; Humans ; Immunosuppressive Agents/therapeutic use ; Medicare ; Tasmania ; United States
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies